廣(guang)(guang)東(dong)健信(xin)制(zhi)藥(yao)股份有限公司(si)創始于2006年,位于廣(guang)(guang)東(dong)省汕頭市三聯工(gong)業(ye)區珠浦片區健信(xin)醫藥(yao)工(gong)業(ye)園。是(shi)一(yi)家集研(yan)(yan)(yan)發(fa)、生產、銷售為一(yi)體(ti)的現(xian)代化(hua)制(zhi)藥(yao)企業(ye)。擁(yong)有按照GMP藥(yao)品生產規范(fan)設計建設的凍干粉針劑(ji)藥(yao)品生產車(che)間(jian)、原料藥(yao)合成生產車(che)間(jian)及二類醫療器械生產車(che)間(jian),于2014年12月順利通(tong)過GMP認證(zheng),2015年5月份取得GMP證(zheng)書。企業(ye)擁(yong)有自主研(yan)(yan)(yan)發(fa)實驗(yan)室以(yi)及雄厚的新(xin)藥(yao)研(yan)(yan)(yan)究實力,配置了知名的試驗(yan)、檢驗(yan)儀器以(yi)及高素質的專業(ye)人(ren)才。已被認定(ding)為“國家高新(xin)技(ji)術企業(ye)”、“汕頭市民營科技(ji)企業(ye)”,成立了“汕頭市新(xin)藥(yao)研(yan)(yan)(yan)制(zhi)工(gong)程技(ji)術研(yan)(yan)(yan)究開(kai)發(fa)中心”,著力于新(xin)藥(yao)的研(yan)(yan)(yan)究開(kai)發(fa)工(gong)作。
目前已研(yan)究開(kai)發(fa)上市(shi)的(de)新藥品種有(you)國家三(san)類(lei)新藥——注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)鹽(yan)酸(suan)多西環素、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)泮托拉(la)唑鈉、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)左(zuo)卡尼汀(ting)、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)乙胺硫脲、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)鹽(yan)酸(suan)索(suo)他(ta)洛(luo)爾、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)煙酸(suan)占替(ti)諾、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)去甲斑蝥酸(suan)鈉、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)尿激酶、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)甲磺酸(suan)培(pei)氟沙星、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)環磷(lin)腺苷、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)布(bu)美(mei)他(ta)尼、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)奧扎格雷(lei)鈉、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)奧美(mei)拉(la)唑鈉、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)阿魏(wei)酸(suan)鈉、注(zhu)(zhu)(zhu)(zhu)射(she)(she)用(yong)(yong)(yong)(yong)(yong)(yong)棓丙酯(zhi)、布(bu)美(mei)他(ta)尼注(zhu)(zhu)(zhu)(zhu)射(she)(she)液等16個(ge)產(chan)品25個(ge)品規的(de)藥品,且有(you)10個(ge)新藥項(xiang)目處于研(yan)究開(kai)發(fa)階段。企業已取得四項(xiang)發(fa)明專利。